Filing Details
- Accession Number:
- 0000903423-18-000564
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-18 17:03:29
- Reporting Period:
- 2018-10-16
- Accepted Time:
- 2018-10-18 17:03:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | X0 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1131399 | Plc Glaxosmithkline | 980 Great West Road Brentford Middlesex X0 TW8 9GS | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-10-16 | 7,343,492 | $11.69 | 0 | No | 4 | S | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Footnote |
Footnotes
- Shares of Common Stock were held of record by Glaxo Group Limited, which is an indirect wholly-owned subsidiary of Reporting Person.
Billionaire Hedge Funds
